Airato

AiRato is a Japanese startup specializing in AI-driven radiation therapy solutions aimed at improving the quality and efficiency of cancer treatment. The company focuses on developing advanced AI technology to assist both patients and medical professionals in making better treatment decisions. AiRato operates in the healthcare sector, specifically targeting the oncology market, which is experiencing growing demand due to increasing cancer diagnoses and longer working life expectancies. The business model revolves around creating AI products that meet the clinical needs of radiotherapy environments, particularly in the area of Intensity Modulated Radiotherapy (IMRT). This technique, while highly effective, faces challenges such as variations in treatment plan quality, lengthy preparation times, and difficulties in staff training. AiRato's AI solutions aim to address these issues, thereby enhancing the overall treatment process. The company generates revenue through the sale and licensing of its AI software to hospitals and medical institutions.

Keywords: AI, radiation therapy, oncology, cancer treatment, IMRT, healthcare, medical technology, Japan, clinical solutions, efficiency.